The UK National Screening Committee (UKNSC) is consulting on its guidance covering the development, production and review of information to support all UK population screening programmes.
The PHE inequalities strategy will aim to close the screening inequalities gap and ensure equitable access to screening to all eligible populations.
I’m the Sickle Cell and Thalassaemia Screening Lead at Northampton General Hospital and Kettering General Hospital. For the past year I’ve been on secondment as national project lead for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
We expect local screening services to use our guidance on Managing Safety Incidents in the NHS Screening Programmes if they think they have a safety incident or serious incident. It’s relevant to all 11 national population screening programmes. This new version replaces the previous one from October 2015.
We’ve now published the screening key performance indicator (KPI) data for the fourth quarter of 2016 to 2017 (Q4, January to March 2017). The KPIs are used to measure how NHS screening programmes are performing and aim to give a high level overview of programme quality.
More than 100 abdominal aortic aneurysm (AAA) screening professionals attended this year’s national AAA screening networking event.
NHS England has published the 2017-18 service specifications for all 11 NHS Screening Programmes. The specifications accompany the 2017-18 agreement that outlines how NHS England commissions certain public health services under section 7A of the National Health Service Act 2006.
Screening folk can be a loyal bunch – either that or it’s a difficult discipline to escape from! A colleague of mine recently reached the amazing milestone of working 30 years in screening, making me reflect on my own career.
The next screening masterclasses will be in Skipton House, London on 11 September 2017 and 14 November 2017. Read this blog and book your place.
The NHS Breast Screening Programme has produced new guidance on the reporting, classification and monitoring of interval cancers. These are cancers diagnosed after a screening appointment at which a woman received a normal result and before her next scheduled screening appointment.
More than 40 people attended a regional diabetic eye screening (DES) networking day organised by the Midlands and East Screening QA Service (SQAS) team. Delegates included programme managers, clinicians, senior screeners, senior graders and public health commissioners.